Anúncio
Anúncio

KRRO

KRRO logo

Korro Bio, Inc. Common Stock

8.48
USD
Patrocinado
+0.22
+2.72%
07 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

8.48

0.00
-0.06%

Relatórios de Lucros KRRO

Rácio de surpresa positiva

KRRO separação 13 de 25 últimas estimativas.

52%

Próximo Relatório

Data do Próximo Relatório
16 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$708.17K
/
-$2.16
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-35.03%
/
+12.50%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-68.82%
/
-4.00%

Korro Bio, Inc. Common Stock earnings per share and revenue

On 12 de nov. de 2025, KRRO reported earnings of -1.92 USD per share (EPS) for Q3 25, beating the estimate of -2.64 USD, resulting in a 27.43% surprise. Revenue reached 1.09 milhão, compared to an expected 589.78 mil, with a 84.81% difference. The market reacted with a -79.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -2.16 USD, with revenue projected to reach 708.17 mil USD, implying an aumentar of 12.50% EPS, and diminuir of -35.03% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Korro Bio, Inc. Common Stock reported EPS of -$1.92, beating estimates by 27.43%, and revenue of $1.09M, 84.81% above expectations.
The stock price moved down -79.31%, changed from $31.42 before the earnings release to $6.50 the day after.
The next earning report is scheduled for 16 de mar. de 2026.
Based on 12 analistas, Korro Bio, Inc. Common Stock is expected to report EPS of -$2.16 and revenue of $708.17K for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio